Concepedia

Venkata Ramana Doppalapudi

VR

Statistics

Publications

22

Citations

1.1K

H-Index

17

Active since

1999

Affiliations

Southern Methodist University(Current)

Pfizer (United States)

Fleet Science Center

Avidity (United States)

Venkata Ramana Doppalapudi is an author at Southern Methodist University specializing in pharmacology, pharmacy, and medicinal chemistry.

Publications per year

1999–2025

22

Publications

22

Specifically Targeting Angiopoietin-2 Inhibits Angiogenesis, Tie2-Expressing Monocyte Infiltration, and Tumor Growth

Hanhua Huang, Jing-Yu Lai, Janet Do et al. · Clinical Cancer Research · 2011 · 141 citations

, , +17

Targeted tissue delivery of RNA therapeutics using antibody–oligonucleotide conjugates (AOCs)

Barbora Malecová, Rob S. Burke, Michael A. Cochran et al. · Nucleic Acids Research · 2023 · 137 citations · Full text

, , +17

Chemical generation of bispecific antibodies

Venkata Ramana Doppalapudi, Jie Huang, Dingguo Liu et al. · Proceedings of the National Academy of Sciences · 2010 · 126 citations · Full text

, , +17

Optimization of Tubulysin Antibody–Drug Conjugates: A Case Study in Addressing ADC Metabolism

L. Nathan Tumey, Carolyn A. Leverett, Beth C. Vetelino et al. · ACS Medicinal Chemistry Letters · 2016 · 70 citations · Full text

, , +17

Inhibition of Class C β-Lactamases:  Structure of a Reaction Intermediate with a Cephem Sulfone<sup>,</sup>

G.V. Crichlow, Michiyoshi Nukaga, Venkata Ramana Doppalapudi et al. · Biochemistry · 2001 · 63 citations

, , +13

1–5 of 22